SHELTON CAPITAL MANAGEMENT - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 39 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
SHELTON CAPITAL MANAGEMENT ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$158,000
-40.6%
128,5320.0%0.01%
-30.0%
Q1 2022$266,000
-24.0%
128,532
-46.4%
0.01%
-16.7%
Q4 2021$350,000
-45.0%
240,0000.0%0.01%
-52.0%
Q3 2021$636,000
-27.0%
240,000
+9.1%
0.02%
-24.2%
Q2 2021$871,000
-17.0%
220,0000.0%0.03%
-10.8%
Q1 2021$1,049,000220,0000.04%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 37,191$139,0000.08%
ARK Investment Management 539,417$2,017,0000.04%
Nikko Asset Management Americas, Inc. 215,742$807,0000.01%
ETF MANAGERS GROUP, LLC 44,571$178,0000.01%
Verition Fund Management LLC 20,550$77,0000.00%
Renaissance Technologies 186,231$697,0000.00%
Certified Advisory Corp 500$2,0000.00%
Sumitomo Mitsui Trust Holdings, Inc. 215,742$807,0000.00%
MORGAN STANLEY 1,580$5,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 18,170$68,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders